Evidence map›Paper›PMID 41947088›Full record

ArticleBMC cancer2026

Prognostic nutritional index improved the survival prediction of the revised Tokuhashi and Tomita scores for patients with lung cancer spinal metastases.

Tiantian Wei, Guoqing Zhong, Jinfeng Wang, Chongquan Huang, Jin Qian, Yijie He, Yonghan Chen, Jingzhe He, Maolin Zhou, Shi Cheng and 2 more

Abstract read
In one paragraph

Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Tiantian Wei *Department of Orthopedics, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Zhongshan 2nd Road, Room 1042, 10/F, Main Clinical Building, Guangzhou, Guangdong, 510000, China.
Guoqing Zhong *Department of Bone and Soft Tissue Cancer, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, 127# Dongming Road, Zhengzhou, 450008, China.
Jinfeng Wang *Department of Orthopedics, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Zhongshan 2nd Road, Room 1042, 10/F, Main Clinical Building, Guangzhou, Guangdong, 510000, China.
Chongquan HuangDepartment of Orthopedics, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Zhongshan 2nd Road, Room 1042, 10/F, Main Clinical Building, Guangzhou, Guangdong, 510000, China.
Jin QianDepartment of Orthopedics, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Zhongshan 2nd Road, Room 1042, 10/F, Main Clinical Building, Guangzhou, Guangdong, 510000, China.
Yijie HeDepartment of Orthopedics, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Zhongshan 2nd Road, Room 1042, 10/F, Main Clinical Building, Guangzhou, Guangdong, 510000, China.
Yonghan ChenDepartment of Orthopedics, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Zhongshan 2nd Road, Room 1042, 10/F, Main Clinical Building, Guangzhou, Guangdong, 510000, China.
Jingzhe HeDepartment of Orthopedics, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Zhongshan 2nd Road, Room 1042, 10/F, Main Clinical Building, Guangzhou, Guangdong, 510000, China.
Maolin ZhouState Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital, Guangzhou Medical University, 151# Yanjiang Road, Guangzhou, Guangdong, 510120, China.
Shi ChengDepartment of Orthopedics, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Zhongshan 2nd Road, Room 1042, 10/F, Main Clinical Building, Guangzhou, Guangdong, 510000, China. 120695479@qq.com.
Chengzhi ZhouState Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital, Guangzhou Medical University, 151# Yanjiang Road, Guangzhou, Guangdong, 510120, China.
Yu ZhangDepartment of Orthopedics, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Zhongshan 2nd Road, Room 1042, 10/F, Main Clinical Building, Guangzhou, Guangdong, 510000, China. luck_2001@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesLung cancer is currently the leading cause of cancer-related deaths worldwide, with 30%-36% of patients developing spinal metastases. However, the predictive accuracy of commonly used spinal metastasis scoring systems, such as the revised Tokuhashi score and Tomita score, has decreased. This study aims to optimize the revised Tokuhashi and Tomita scores by incorporating new indicators to assist clinicians in making informed treatment decisions.

methodsA retrospective analysis was conducted on 147 patients with lung cancer spinal metastases. Prognostic factors were identified using Cox regression analysis. The predictive performance of different models at the 3-month, 6-month, and 1-year time points was evaluated using receiver operating characteristic (ROC) curves and the DeLong test.

resultsBy incorporating the Prognostic Nutritional Index (PNI) and the presence of non-small cell lung cancer, the optimized P-Tokuhashi and P-Tomita scores were developed. The predictive abilities of P-Tokuhashi at 3 months (AUC = 0.77), 6 months (AUC = 0.71), and 1 year (AUC = 0.74), as well as P-Tomita at 3 months (AUC = 0.74), 6 months (AUC = 0.62), and 1 year (AUC = 0.70), were all superior to the pre-optimization scores. The DeLong test confirmed that the predictive accuracy of the modified scores at 6 months and 1 year was significantly better than that of the original scores (p < 0.05).

conclusionThe new prognostic scoring system for spinal metastasis, which incorporates the PNI and the status of non-small cell lung cancer (NSCLC), provides better prediction of survival in patients with lung cancer spinal metastases, enabling clinicians to select more personalized treatment strategies.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsNutrition AssessmentSpinal NeoplasmsAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedPrognosisRetrospective StudiesROC CurveAUCLung cancerPrognosticSpine metastasis

Identifiers

PMID41947088
PMCPMC13188505

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.